Levenscyclus & insolventie-signalen
0 gebeurtenissen uit het Belgisch Staatsblad
Geen insolventiesignalen in het Belgisch Staatsblad
Belgisch Staatsblad — aktes
60 aktes Kapitaalverloop · 21
28-11-2025
v3.2
28-11-2025
Kapitaalwijziging
28-11-2025
v3.2
27-05-2024
Kapitaalwijziging
27-05-2024
v3.2
27-05-2024
v3.2
31-01-2024
v3.2
31-01-2024
v3.2
31-01-2024
Kapitaalwijziging
17-05-2023
v3.2
17-05-2023
Kapitaalwijziging
17-05-2023
v3.2
18-10-2022
Kapitaalwijziging
18-10-2022
v3.2
18-10-2022
v3.2
Adresverloop · 4
15-02-2022
Zetelwijziging
15-02-2022
v3.2
23-11-2015
Zetelwijziging
23-11-2015
v3.2
Alle aktes · 60
bijgewerkt 7 maanden geleden
2025
28-11-2025 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-11-20",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}28-11-2025 Statutenwijziging — vertaling van de statuten en coördinatie van de statuten
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-28",
"filing_date": "2025-11-26",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), KAPITAAL, AANDELEN"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2024-05-13",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0641.953.324",
"name_full_after": "Ceres Pharma",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Ceres Pharma",
"current_zetel_raw": "Kortrijksesteenweg 1091 bus B",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [],
"articles_modified": [],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_kind"
],
"split_ratio": null,
"shares_after": 167917449,
"shares_before": null,
"capital_after_eur": 50375234.71,
"capital_before_eur": null,
"share_classes_after": []
},
"coordinated_text_lineage": null
}28-11-2025 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
},
"legal_form_change": {
"new": "",
"old": "Naamloze vennootschap",
"changed": false
}
}28-11-2025 Kapitaalverhoging van €50.375.234,71 tot €50.375.234,71
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 50375234.71,
"currency": "EUR",
"after_eur": 50375234.71,
"delta_eur": 50375234.71,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-05-13",
"evidence_quote": "De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd op EUR 50.375.234,71",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}28-11-2025 Kapitaalverhoging
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 167917449,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-28",
"filing_date": "2025-11-26",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-05-13",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": []
}28-11-2025 Kapitaalverhoging tot €50.375.234,71
- Inbreng in natura · Apport en nature
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 50375234.71,
"delta_eur": null,
"before_eur": null,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}19-08-2025 1 bestuurder benoemd, 1 ontslagnemend
- Wouter Coppens — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "Culliganlaan 5, 1831 Diegem",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-07-01",
"evidence_quote": "De Firma PwC Bedrijfsrevisoren zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van Commissaris, ter vervanging van de heer Peter Opsomer.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 3
},
"rep_rotation_new_rep": "Wouter Coppens",
"rep_rotation_old_rep": "Peter Opsomer",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "Culliganlaan 5, 1831 Diegem",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Deze vennootschap wijst overeenkomstig artikel 3:60 WVV Wouter Coppens BV, aan, voor de uitoefening van het mandaat, met als vaste vertegenwoordiger Wouter Coppens, bedrijfsrevisor.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Peter Opsomer",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "mandate_termination_de_plein_droit",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Het mandaat vervalt na de algemene vergadering die de jaarrekening per 31 december 2025 dient goed te keuren",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": 2025
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-08-07",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-06-23",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma NV",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Mario Debel",
"org_rep_person_name": null,
"person_role_at_subject": "Aandeelhouder/Bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}19-08-2025 Wouter Coppens benoemd tot commissaris
- Wouter Coppens — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-07-01",
"evidence_quote": "De algemene vergadering benoemt PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}19-08-2025 1 bestuurder benoemd, 1 ontslagnemend
- Wouter Coppens — Commissaris
- Peter Opsomer — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_in",
"role": "Commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Commissaris",
"person": {
"rrn": null,
"name": "Peter Opsomer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma NV"
}
}2024
03-09-2024 Wouter Coppens herbenoemd als commissaris
- Wouter Coppens — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0641953324",
"name": "PwC Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-07-01",
"evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}03-09-2024 1 bestuurder benoemd, 1 ontslagnemend
- Wouter Coppens — Commissaris
- Peter Opsomer — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Peter Opsomer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}03-09-2024 1 bestuurder benoemd, 1 ontslagnemend
- Wouter Coppens — Commissaris
- Peter Opsomer — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-07-01",
"evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": "Wouter Coppens",
"rep_rotation_old_rep": "Peter Opsomer",
"effective_date_qualifier": null
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Peter Opsomer",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-07-01",
"evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Peter Opsomer",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Mario Debel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Ceres Invest BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-09-03",
"filing_date": "2024-08-23",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-06-23",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Mario Debel",
"org_rep_person_name": null,
"person_role_at_subject": "Aandeelhouder/Bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}27-05-2024 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}27-05-2024 Kapitaalverhoging van €4.608.796,87 tot €50.375.234,71
- €45.766.437,84 → €50.375.234,71
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 50375234.71,
"delta_eur": 4608796.87,
"before_eur": 45766437.84,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 15362656,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.3
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-05-27",
"filing_date": "2024-05-23",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-05-13",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "PwC Bedrijfsrevisoren BV",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Wouter Coppens"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van het bestuursorgaan",
"het verslag van de commissaris"
],
"shareholders_after": [],
"share_classes_after": []
}27-05-2024 Kapitaalverhoging van €4.608.796,87 tot €50.375.234,71
- €45.766.437,84 → €50.375.234,71
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 4608796.87,
"currency": "EUR",
"after_eur": 50375234.71,
"delta_eur": 4608796.87,
"before_eur": 45766437.84,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-05-13",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van EUR 4.608.796,87, om het van EUR 45.766.437,84 te brengen op EUR 50.375.234,71, door uitgifte van 15.362.656 aandelen ... De vergadering beslist dat de kapitaalverhoging zal worden verwezenlijkt door de inbreng door de enige aandeelhouder van een zekere, vaststaande en opeisbare schuldvordering",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}27-05-2024 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-05-13",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "de conclusies van het verslag van de commissaris de dato 10 mei 2024, opgesteld door de besloten vennootschap \u201CPricewaterhouseCoopers Bedrijfsrevisoren\u201D, te Gent, vertegenwoordigd door de heer Wouter Coppens, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"firm_kbo": null,
"firm_name": "PricewaterhouseCoopers Bedrijfsrevisoren",
"ibr_number": null,
"individual_name": "Wouter Coppens"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}27-05-2024 Kapitaalverhoging van €4.608.796,87 tot €50.375.234,71
- €45.766.437,84 → €50.375.234,71
- Inbreng in natura · Apport en nature
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 50375234.71,
"delta_eur": 4608796.869999997,
"before_eur": 45766437.84,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}31-01-2024 Kapitaalverhoging van €9.999.999,90 tot €45.766.437,84
- €35.766.437,94 → €45.766.437,84
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 9999999.9,
"currency": "EUR",
"after_eur": 45766437.84,
"delta_eur": 9999999.9,
"before_eur": 35766437.94,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-12-21",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 9.999.999,90 EUR, om het van 35.766.437,94 EUR te brengen op 45.766.437,84 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}31-01-2024 Kapitaalverhoging van €9.999.999,90 tot €45.766.437,84
- €35.766.437,94 → €45.766.437,84
- Inbreng in geld · Apport en numéraire
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 45766437.84,
"delta_eur": 9999999.900000006,
"before_eur": 35766437.94,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}31-01-2024 Kapitaalverhoging van €9.999.999,90 tot €45.766.437,84
- €35.766.437,94 → €45.766.437,84
- Inbreng in geld · Apport en numéraire
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 45766437.84,
"delta_eur": 9999999.9,
"before_eur": 35766437.94,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 33333333,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.3
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 9999999.9,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-31",
"filing_date": "2024-01-29",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-21",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"een volmacht",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholders_after": [],
"share_classes_after": []
}2023
17-05-2023 Kapitaalverhoging van €3.499.997,94 tot €35.766.437,94
- €32.266.440 → €35.766.437,94
- Inbreng in geld · Apport en numéraire
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 35766437.94,
"delta_eur": 3499997.9399999976,
"before_eur": 32266440.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}17-05-2023 Kapitaalverhoging van €3.499.997,94 tot €35.766.437,94
- €32.266.440 → €35.766.437,94
- Inbreng in geld · Apport en numéraire
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 35766437.94,
"delta_eur": 3499997.94,
"before_eur": 32266440.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 11666660,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.3
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 3499997.94,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-05-17",
"filing_date": "2023-05-15",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-05-05",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholders_after": [],
"share_classes_after": []
}17-05-2023 Kapitaalverhoging van €3.499.997,94 tot €35.766.437,94
- €32.266.440 → €35.766.437,94
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 3499997.94,
"currency": "EUR",
"after_eur": 35766437.94,
"delta_eur": 3499997.94,
"before_eur": 32266440.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-05-05",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 3.499.997,94 EUR, om het van 32.266.440,00 EUR te brengen op 35.766.437,94 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}2022
18-10-2022 Kapitaalverhoging van €10.329.960 tot €32.566.400
- €22.236.440 → €32.566.400
- 4 kapitaalbewegingen in deze akte
Notaris:
Tim CARNEWAL · BrusselKantoor:
BERQUIN NOTARISSEN
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10356000.0,
"delta_eur": 4356000.0,
"before_eur": 6000000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 14520000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.3
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 4356000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 14149440.0,
"delta_eur": 3793440.0,
"before_eur": 10356000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "eenige aandeelhouder",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 12644800,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 22236440.0,
"delta_eur": 8087000.0,
"before_eur": 14149440.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 32566400.0,
"delta_eur": 10329960.0,
"before_eur": 22236440.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-10-18",
"filing_date": "2022-10-14",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-10-28",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "PwC Bedrijfsrevisoren BV",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Peter Opsomer"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"\u00E9\u00E9n volmacht",
"een verslag van het bestuursorgaan",
"een verslag van de commissaris",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": []
}18-10-2022 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}18-10-2022 Kapitaalverhoging van €8.149.440 tot €32.266.440
- €24.117.000 → €32.266.440
- Inbreng in geld · Apport en numéraire
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 32266440,
"delta_eur": 8149440,
"before_eur": 24117000,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma"
}
}18-10-2022 Statutenwijziging
Samenvatting:
v3.2
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-10-06",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "Conclusies van het verslag van de commissaris de dato 5 oktober 2022, opgesteld door de besloten vennootschap \u201CPricewaterhouseCoopers Bedrijfsrevisoren\u201D, te Culliganlaan 5, 1831 Machelen, vertegenwoordigd door Peter Opsomer, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen, luiden letterlijk als volgt: ... waarvoor wij werden aangesteld bij opdrachtbrief van 4 oktober 2022.",
"firm_kbo": null,
"firm_name": "PricewaterhouseCoopers Bedrijfsrevisoren",
"ibr_number": null,
"individual_name": "Peter Opsomer"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-10-2022 Kapitaalverhoging van €4.356.000 tot €28.473.000
- €24.117.000 → €28.473.000
- 2 kapitaalbewegingen in deze akte
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 4356000,
"currency": "EUR",
"after_eur": 28473000,
"delta_eur": 4356000,
"before_eur": 24117000,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-10-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.356.000 EUR, om het van 24.117.000 EUR te brengen op 28.473.000 EUR, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 3793440,
"currency": "EUR",
"after_eur": 32266440,
"delta_eur": 3793440,
"before_eur": 28473000,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-10-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 3.793.440 EUR om het van 28.473.000 EUR te brengen op 32.266.440 EUR, door inbreng in natura",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}15-02-2022 Zetelverplaatsing van Merelbeke naar Sint-Denijs-Westrem
- Lembergsesteenweg 25, bus A, 9820 Merelbeke → Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem
Notaris:
Notaris niet vermeld · Gent
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem",
"city": "Sint-Denijs-Westrem",
"region": "vlaams_gewest",
"street": "Kortrijksesteenweg",
"country": "BE",
"postcode": "9051",
"box_number": "B",
"street_number": "1091",
"locality_suffix": null
},
"old_address": {
"raw": "Lembergsesteenweg 25, bus A, 9820 Merelbeke",
"city": "Merelbeke",
"region": "vlaams_gewest",
"street": "Lembergsesteenweg",
"country": "BE",
"postcode": "9820",
"box_number": "A",
"street_number": "25",
"locality_suffix": null
},
"effective_date": "2022-01-25",
"evidence_quote": "De bestuurder besluit om de zetel te verplaatsen van Lembergsesteenweg 25a, 9820 Merelbeke, naar Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem, met ingang van heden.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Notaris niet vermeld",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2022-01-25",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2022-01-25",
"unanimous": true
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "Ceres Pharma",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Julie De Craecker",
"org_rep_person_name": null,
"person_role_at_subject": "vertegenwoordiging bij administratieve formaliteiten"
},
"co_filed_documents": [
"Bijzondere volmacht voor Julie De Craecker",
"Formulier voor publicatie in het Belgisch Staatsblad"
]
}15-02-2022 Zetelverplaatsing van Merelbeke naar Sint-Denijs-Westrem
- Lembergsesteenweg 25, 9820 Merelbeke → Kortrijksesteenweg 1091, 9051 Sint-Denijs-Westrem
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Sint-Denijs-Westrem",
"region": null,
"street": "Kortrijksesteenweg",
"country": "BE",
"postcode": "9051",
"box_number": "B",
"street_number": "1091"
},
"old_address": {
"city": "Merelbeke",
"region": null,
"street": "Lembergsesteenweg",
"country": "BE",
"postcode": "9820",
"box_number": "A",
"street_number": "25"
},
"effective_date": "2022-01-25",
"evidence_quote": "De bestuurder besluit om de zetel te verplaatsen van Lembergsesteenweg 25a, 9820 Merelbeke, naar Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem, met ingang van heden."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0641.953.324",
"name_full": "CERES PHARMA",
"legal_form": "NV"
}
}Eerste 30 van 60 aktes